New Method to Assess Effectiveness of Genome-Editing Technologies
Droplet Digital™ PCR–based assay quickly and cost-effectively assesses genome-editing events
Droplet Digital™ PCR–based assay quickly and cost-effectively assesses genome-editing events
The multi-constituent control offers increased efficiency and confidence in test results
First Prospective Clinical Trial of Liquid Biopsy with Real-World Clinical Application
The first digital PCR instrument with the CE IVD mark
Helps laboratories identify best QC rules and frequency to assess risk of reporting incorrect test results
Helps Laboratories Identify Best QC Rules and Frequency to Assess Risk of Reporting Incorrect Test Results
Offering Cost Savings, Increased Efficiencies and Less Waste
Designed for small and medium-size transfusion medicine laboratories
Advances in biomarker research using Droplet Digital™ PCR
Stringent Validation and Quality Control Ensure Confidence in Antibodies and Results